Global Metastatic Cancer Treatment Market Forecast 2018-2026

Global Metastatic Cancer Treatment Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Breast Cancer Therapeutic Indication Is Majorly Used
3.2.2. Generic Medicines Are Anticipated To Grow At A Significant Rate
3.2.3. Melanoma Is The Most Prevailing Cancer
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Prevalence of Cancer
4.1.2. Increasing Prevalence And Awareness About Metastatic Cancer
4.1.3. Growing R&D In The Field of Oncology
4.1.4. Rising Aging Population
4.1.5. Advancements In Research & Development
4.1.6. Promised Potential of Alternative Therapies
4.2. Market Restraints
4.2.1. Adverse Side Effects of Chemotherapy
4.2.2. Reimbursement Issue
4.2.3. Poor Retention And Recruitment In Cancer Clinical Research Trials
4.3. Market Opportunities
4.3.1. Targeted Drug Therapies Are Rising
4.3.2. Increasing Population With High Risk of Metastatic Cancer
4.3.3. Development of Cost-Effective Cancer Drugs
4.3.4. Strategic Approach Taken By The Cancer Drug Manufacturers
4.4. Market Challenges
4.4.1. High Price Tags of Cancer Drugs
4.4.2. Rigorous Regulatory Agenda
4.4.3. High Capital Investment
5. Market Segmentation
5.1. Market By Therapeutic Indication 2018-2026
5.1.1. Breast Cancer
5.1.2. Prostate Cancer
5.1.3. Lung Cancer
5.1.4. Melanoma
5.1.5. Colorectal Cancer
5.1.6. Other Therapeutic Applications
5.2. Market By Products 2018-2026
5.2.1. Branded Medicines
5.2.2. Generic Medicines
6. Key Analytical
6.1. Porter's Five Forces Analysis
6.1.1. Threat of New Entrant
6.1.2. Threat of Substitute
6.1.3. Bargaining Power of Buyers
6.1.4. Bargaining Power of Suppliers
6.1.5. Intensity of Competitive Rivalry
6.2. Oncology Drugs Approvals By The Fda
6.3. Routes of Metastasis
6.4. Regulatory Framework
6.4.1. Regulations In North America
6.4.2. Regulations In Europe
6.4.3. Regulations In Asia Pacific
6.4.4. Regulations In Latin America
6.4.5. Regulations In Middle East And Africa
6.5. Regulatory Designations
6.6. Patent Analysis
6.7. Pipeline Analysis
7. Geographical Segmentation
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Russia
7.2.7. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. Australia
7.3.5. South Korea
7.3.6. Rest of Apac
7.4. Rest of World
7.4.1. Latin America
7.4.2. Middle East And Africa
8. Company Profiles
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Abbvie Inc.
8.2.1. Company Profiles
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Amgen, Inc.
8.3.1. Company Profiles
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Astrazeneca Plc
8.4.1. Company Website
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Bayers Ag
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Bristol-Myers Squibb
8.6.1. Company Profiles
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Celgene Corporation
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Eli Lilly And Company
8.8.1. Company Overview
8.8.2. Products Portfolio
8.8.3. Swot Analysis
8.8.4. Strategic Initiatives
8.9. F. Hoffmann-La Roche Ltd
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Johnson & Johnson
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Swot Analysis
8.10.4. Strategic Initiatives
8.11. Merck & Co., Inc.
8.11.1. Company Profiles
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Novartis Ag
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Pfizer, Inc.
8.13.1. Company Profiles
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Sanofi
8.14.1. Company Overview
8.14.2. Products Portfolio
8.14.3. Swot Analysis
8.14.4. Strategic Initiatives
8.15. Takeda Pharmaceutical Company Limited
8.15.1. Company Overview
8.15.2. Products Portfolio
8.15.3. Swot Analysis
8.15.4. Strategic Initiatives

List of Tables

Table 1 Global Metastatic Cancer Treatment Market By Geography 2018-2026 ($ Million)
Table 2 R&D Expense By Major Pharmaceutical Companies In 2017
Table 3 Recent Approvals of Metastatic Cancer Drugs
Table 4 Adverse Side Effects of Metastatic Cancer Drugs
Table 5 Global Metastatic Cancer Treatment Market By Therapeutic Application 2018-2026 ($ Million)
Table 6 Company's Manufacturing Drugs For Other Therapeutic Indications
Table 7 Global Metastatic Cancer Treatment Market By Products 2018-2026 ($ Million)
Table 8 Branded Drugs Used To Treat Metastatic Cancer
Table 9 Generic Drugs Used To Treat Metastatic Cancer
Table 10 Patent Products With The Expiry Date
Table 11 Patent Publications Related To Metastatic Breast Cancer 2017
Table 12 Patent Publications Related To Metastatic Prostate Cancer 2017
Table 13 Patent Publications Related To Metastatic Lung Cancer 2017
Table 14 Pipeline Analyses of Metastatic Cancer Drugs
Table 15 Global Metastatic Cancer Treatment Market By Geography 2018-2026 ($ Million)
Table 16 North America Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Table 17 Europe Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Table 18 Asia Pacific Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Table 19 State-Wise Distribution of Cancer In India
Table 20 Estimated Most Common Cancers Diagnosed In Australia 2017
Table 21 Rest of World Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figures List
Figure 1 Global Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 2 Targeted Therapies For Different Cancer Types
Figure 3 Global Metastatic Cancer Treatment Market In Breast Cancer 2018-2026 ($ Million)
Figure 4 Symptoms of Metastatic Breast Cancer
Figure 5 Global Metastatic Cancer Treatment Market In Prostate Cancer 2018-2026 ($ Million)
Figure 6 Global Metastatic Cancer Treatment Market In Lung Cancer 2018-2026 ($ Million)
Figure 7 Global Metastatic Cancer Treatment Market In Melanoma 2018-2026 ($ Million)
Figure 8 Global Metastatic Cancer Treatment Market In Colorectal Cancer 2018-2026 ($ Million)
Figure 9 Global Metastatic Cancer Treatment Market In Other Therapeutic Applications 2018-2026 ($ Million)
Figure 10 Global Metastatic Cancer Treatment Market In Branded Medicines 2018-2026 ($ Million)
Figure 11 Global Metastatic Cancer Treatment Market In Generic Medicines 2018-2026 ($ Million)
Figure 12 The United States Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 13 Canada Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 14 The United Kingdom Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 15 Germany Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 16 France Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 17 Italy Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 18 Spain Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 19 Russia Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 20 Rest of Europe Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 21 China Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 22 India Pacific Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 23 Japan Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 24 Australia Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 25 South Korea Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 26 Rest of Apac Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 27 Latin America Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 28 Middle East And Africa Metastatic Cancer Treatment Market 2018-2026 ($ Million)
Figure 29 Market Share of Key Players In Metastatic Cancer 2017 (%)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs